Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-31 @ 4:18 PM
Study NCT ID:
NCT03963193
Status:
UNKNOWN
Last Update Posted:
2019-05-24
First Post:
2019-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Etoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 Type
Sponsor:
Henan Cancer Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2019-05-20
First Submit QC Date:
None
Study First Post Date:
2019-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-23
Last Update Post Date:
2019-05-24
Last Update Post Date Type:
ACTUAL